QNRX — Quoin Pharmaceuticals Balance Sheet
0.000.00%
Last trade - 00:00- $2.31m
- -$9.01m
Annual balance sheet for Quoin Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | C2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | 20-F | 6-K | 10-K | 10-K |
| Standards: | IFRS | IFRS | USG | USG | USG |
| Status: | fx Final | fx Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 5.24 | 5.28 | 7.48 | 12.9 | 10.7 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.136 | 0.088 | — | — | — |
| Prepaid Expenses | |||||
| Total Current Assets | 5.38 | 5.37 | 8.5 | 13.4 | 11.3 |
| Net Property, Plant And Equipment | 0.673 | 0.603 | — | — | — |
| Net Intangible Assets | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 6.18 | 6.1 | 9.36 | 14.5 | 12.2 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 1.05 | 0.93 | 4.58 | 3.53 | 3.58 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 1.88 | 1.43 | 8.7 | 7.05 | 6.51 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Total Equity | 4.3 | 4.67 | 0.657 | 7.41 | 5.66 |
| Total Liabilities & Shareholders' Equity | 6.18 | 6.1 | 9.36 | 14.5 | 12.2 |
| Total Common Shares Outstanding |